Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD).

Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role ...

Lupus is a chronic disease that can cause inflammation and pain in any part of the body. It’s an autoimmune disease, which ...

Objectives SLE is a multifaceted autoimmune disorder with a complex pathogenesis involving genetic, environmental and ...

Dr Sudhir Karmacharya, a lupus specialist at the National Center for Rheumatic Diseases (NECRD), stated that lupus is more ...

A new study published in JAMA Dermatology reveals that people with cutaneous lupus are 72 per cent more likely to develop ...

Heat rash, including prickly heat, often goes away without treatment. The first step to soothing prickly heat is to move away from the irritant (or environment) causing your skin to break out in a ...

The Phase 1 GALLOP study evaluating investigational therapy, CB-010, for treatment of lupus nephritis (LN) has officially started. This open label, multicenter study will assess a single infusion of ...

Lupus nephritis (LN) is one of the most serious ... Results from these studies bring new insights for real effective treatment in LN and thus achieve a better outcome in patients.

There are many treatments available for MS, many of which can help decrease the frequency and severity of relapses, improve physical function, and ease symptoms caused by the condition.

Learn more about the types of lupus. Doctors consider the antibiotic dapsone to be the first-line treatment for mild BSLE. BSLE typically responds rapidly to dapsone therapy and resolves within 1 ...

Lupus affects different people in different ways, and skin problems like rashes or sores are common. In a new study, people with systemic lupus erythematosus (SLE) were found to be at higher risk for ...